Beam Therapeutics Inc
BEAM
Market Cap$1.66B
Close$
$-24.21
230.6% downside
Current Fair Value
230.6% downsideOvervalued by 230.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.66 Billion |
|---|---|
| Enterprise Value | $1.78 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.58 |
| Beta | 2.23 |
| Outstanding Shares | 101,995,184 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.19 |
|---|---|
| PEG | -33.91 |
| Price to Sales | - |
| Price to Book Ratio | 1.85 |
| Enterprise Value to Revenue | 29.46 |
| Enterprise Value to EBIT | -4.09 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
ESG Score
No data